September 2007
MRSA Lives Among Us
Jean Svendsen, RN
Chief Nurse Consultant
Tracy Powell, MPH
Advanced Analysis Epidemiologist
Staphylococcus
aureus, or “staph”, is a common bacterium that lives on the human skin
(armpit, groin, and genital areas) and in the nasal passageways of many people.
Although staph bacteria are usually harmless, they can cause skin and soft
tissue infections, such as pimples, boils, and cellulitis. Staph is one of the
most common causes of skin infections in the U.S.
MRSA (Methicillin-resistant Staphylococcus aureus) is a
strain of staph that is resistant to methicillin and other related antibiotics.
The first reported U.S. outbreak of MRSA occurred in 1968 in a Boston hospital,
seven years after the first reported case. Since MRSA can be resistant to
several different antibiotics, infections can be difficult to treat.1
MRSA is most commonly associated with hospitalized patients,
long-term care facilities, and healthcare workers (healthcare acquired or HA-MRSA).
HA-MRSA infections have risen sharply in recent years. In the U.S. in 1972, HA-MRSA
accounted for only 2 percent of all healthcare-acquired infections. reported to
the Centers for Disease Control and Prevention (CDC). Recent data show that HA-MRSA
now accounts for 50-70 percent of healthcare-acquired infections.2
In the past several years, MRSA has emerged into the community,
where its incidence has greatly increased.3 The CDC defines
community-acquired MRSA (CA-MRSA) as MRSA infections that are acquired by
individuals who have not been hospitalized within the last year or had a medical
procedure. Most CA-MRSA infections are seen as skin and soft tissue infections
such as pimples, boils, abscesses, and cellulitis and occur in otherwise healthy
people. MRSA skin infections often appear red, swollen, painful, and have a
pus-like discharge. More serious infections may cause pneumonia and bone,
bloodstream, or surgical wound infections.
In Indiana, most CA-MRSA
cases originate in correctional facilities and competitive sports teams4
in high schools and colleges. Infections have been associated with direct
skin-to-skin contact through cuts and abrasions and indirect contact, such as
sharing contaminated sports equipment, towels, and clothing as well as crowded
living conditions, and poor hygiene. Individual cases of MRSA are not reportable
in Indiana, because the infection is so common. However, any suspected clusters
or outbreaks are immediately reportable to local health departments for
investigation.
As with any infectious disease, prevention is key. The CDC
recommends the following practices to help prevent spreading staph or MRSA skin
infections:
-
Clean your hands.
Hand hygiene plays a vital role in reducing the transmission of infection.
Wash hands frequently with soap and water or use an alcohol-based hand
sanitizer, especially after changing bandages or touching an infected wound.
-
Cover your wounds. Wounds that are draining or have pus should
be covered with clean, dry bandages. Follow your healthcare provider’s
instructions on proper wound care. Pus from infected wounds can contain staph
and MRSA, so keeping the infection covered will help prevent the spread to
others. Bandages or tape can be discarded in the regular trash.
-
Do not share personal items. Avoid sharing personal items such
as towels, washcloths, razors, clothing, or uniforms that may have had contact
with infected wounds or bandages. Use hot water and laundry detergent to wash
soiled sheets, towels, and clothing. Dry items in a clothes dryer on the
hottest setting possible, rather than air-dry, to help kill bacteria.
-
Talk to your healthcare provider. Tell your healthcare
providers who treat you that you have or have had a staph or MRSA skin
infection. See your healthcare provider promptly if you have wounds that do
not heal or appear red, swollen, draining, or painful.
You can learn more about MRSA by visiting the following Web
sites:
http://www.in.gov/isdh/healthinfo/mrsa.htm
http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_public.html
________________________
References
-
Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant
Staphylococcus aureus at Boston City Hospital: bacteriologic and
epidemiologic observation. New England Journal of Medicine 1968; 279:441-448.
-
Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare
Infection Control Practices Advisory Committee. Management of multi-drug
resistant organisms in healthcare settings, 2006. US Centers for Disease
Control and Prevention. Available at
http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf (accessed
September 19, 2007)
-
Chambers HF. The changing epidemiology of Staphylococcus
aureus? Emerging Infectious Disease 2001;7:178-82. Available at
http://www.cdc.gov/ncidod/eid/vol7no2/chambers.htm (accessed September 19,
2007)
-
Centers for Disease Control and Prevention. Methicillin-resistant
Staphylococcus aureus among competitive sports participants—Colorado,
Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morbidity and
Mortality Weekly Report 2003;52:793-5. Available at
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5233a4.htm (accessed September
19, 2007)
|